Premium
Long‐Term Performance of the Hemodialysis Reliable Outflow (HeRO) Device: The 56‐Month Follow‐Up of the First Clinical Trial Patient
Author(s) -
Nassar George M.
Publication year - 2010
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/j.1525-139x.2010.00713.x
Subject(s) - medicine , hero , term (time) , outflow , hemodialysis , intensive care medicine , surgery , artificial intelligence , meteorology , computer science , physics , quantum mechanics
Abstract The Hemodialysis Reliable Outflow (HeRO ® ) Vascular Access Device is a novel long‐term subcutaneous dialysis graft, ideally suited for catheter‐dependent patients and patients dialyzing with failing fistulas or grafts due to venous outflow stenosis. This case presentation depicts the clinical course of the first patient to enter a Food and Drug Administration approved clinical trial and receive the HeRO device. The course of this patient over 56 months of follow‐up provides the longest experience with the HeRO device to‐date. In this patient, the HeRO device provided long‐term dialysis access patency in conjunction with adequate dialysis and a low intervention rate.